Delivery Order SPE2DB22D3301-SPE2DB25FX4AF

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4AF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of the ADVAIR HFA 230-21 MCG INHALER 12GM medication. The contract has a ceiling value of $33,350.38 and a period of performance through October 21, 2024. This award is a delivery order issued under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract with the DLA, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.

Generated 1/17/25, 9:24 AM